Kymera Therapeutics, Inc.

NORGES BANK KYMR
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/12/2026
Shares
757,246
Value ($000)
86,833
Weight
0.0%
2022 Q4 - 2026 Q2 (7 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).